NAGIOS: RODERIC FUNCIONANDO

Oral implants in patients receiving bisphosphonates : a review and update

Repositori DSpace/Manakin

IMPORTANT: Aquest repositori està en una versió antiga des del 3/12/2023. La nova instal.lació está en https://roderic.uv.es/

Oral implants in patients receiving bisphosphonates : a review and update

Mostra el registre parcial de l'element

dc.contributor.author Mínguez Serra, María Paz es
dc.contributor.author Salort Llorca, Cesar es
dc.contributor.author Silvestre Donat, Francisco Javier es
dc.date.accessioned 2017-12-16T11:53:01Z
dc.date.available 2017-12-16T11:53:01Z
dc.date.issued 2008 es
dc.identifier.citation Mínguez Serra, María Paz ; Salort Llorca, Cesar ; Silvestre Donat, Francisco Javier. Oral implants in patients receiving bisphosphonates : a review and update. En: Medicina oral, patología oral y cirugía bucal. Ed. inglesa, 13 12 2008: 2- es
dc.identifier.uri http://hdl.handle.net/10550/63662
dc.description.abstract This rewiew was mad to establish the convenience of dental implant treatment in patients receiving bisphosphonates or programmed to receive such drugs, with a description of their mechanisms of action and the way in which they can affect the mandibular or maxillary bone of dental implant candidates. In turn, a description is provided of the key elements for evaluating the benefit-risk ratio in patients treated with bisphosphonates who require oral surgery. Clinicians must be aware of the potential risk of osteonecrosis in patients treated with bisphosphonates via the oral or intravenous route. When bisphosphonates are administered via the intravenous route, all invasive oral procedures (including implant surgery) are contraindicated, and should be avoided unless absolutely necessary. The indications are more controversial in the case of bisphosphonates administered via the oral route. There is little literature on the influence of oral bisphosphonates upon bone repair, and there are not many published cases of mandibular or maxillary osteonecrosis among patients that receive such medication. The use of bisphosphonates is becoming increasingly widespread, and the duration of such treatment is increasing. It would be of interest to design studies to evaluate the risk factors of maxillary osteonecrosis among dental implant patients receiving treatment with oral bisphosphonates, and to define biomarkers capable of indicating the level of risk in the event of oral surgery in patients receiving such drugs. es
dc.title Oral implants in patients receiving bisphosphonates : a review and update es
dc.type journal article es_ES
dc.subject.unesco UNESCO::CIENCIAS MÉDICAS es
dc.identifier.doi es
dc.type.hasVersion VoR es_ES

Visualització       (397.1Kb)

Aquest element apareix en la col·lecció o col·leccions següent(s)

Mostra el registre parcial de l'element

Cerca a RODERIC

Cerca avançada

Visualitza

Estadístiques